Roflumilast Foam Improves Symptoms of Scalp, Body Psoriasis
Drug Topics
MAY 8, 2025
The therapy is currently under FDA review and has a PDUFA action date of May 22, 2025.
Thu.May 08, 2025
395 
STAT+: 5 burning questions about FDA’s ‘aggressive’ deployment of AI for scientific review
STAT
MAY 8, 2025
The Food and Drug Administration said it will rapidly roll out a generative artificial intelligence model to assist scientific reviews across the agency, setting up a high-stakes test of the technology’s use in vetting products used in the care of millions of Americans. Calling it a “historic first,” FDA commissioner Marty Makary said on Thursday that the AI tool will be deployed across all of the agency’s review offices by the end of June, following the completion of
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Rite Aid’s Closure is a Call to Action to Address Pharmacy Payment Model
Drug Topics
MAY 8, 2025
A conversation with Douglas Hoey, RPh, MBA, CEO of NCPA, on the chain pharmacys announcement of a second Chapter 11 bankruptcy.
Inside the world of internet peptides
STAT
MAY 8, 2025
A constellation of social media wellness influencers, YouTubers, and podcasters have been extolling the health benefits of peptides. There seems to be a peptide for just about anything you could dream of. Want to lose weight? There are GLP-1s, of course. Would you like to have a year-round tan? You could give melanotan a shot. Have a nagging sports injury?
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
ACE Inhibitors Show Lower Risk of MACE for Older Patients With Type 2 Diabetes
Drug Topics
MAY 8, 2025
Angiotensin-converting enzyme inhibitors have been known to be more effective in decreasing the incidence of major adverse cardiac events for patients with diabetes.
Bill Gates to accelerate spending at his foundation — then wind it down
STAT
MAY 8, 2025
Philanthropist Bill Gates announced Thursday that he will wind down his massive charity in 20 years, doubling spending over that time to accelerate the work it hopes to achieve. Gates made the announcement on the 25th anniversary of the launch of the Gates Foundation, the third-largest player in international philanthropy. He said the foundation would spend $200 billion between now and 2045, when its operations will wind down.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
The Role of Physical Activity in Breast Cancer Risk Reduction and Survival
Pharmacy Times
MAY 8, 2025
Pharmacists can educate patients on non-pharmacologic strategies that help improve survival outcomes.
Tremfya Demonstrates Sustained Response Up to 92 Weeks
Drug Topics
MAY 8, 2025
Guselkumab is the first and only IL-23 inhibitor to demonstrate robust data as a fully subcutaneous regimen.
Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications
PharmaVoice
MAY 8, 2025
With another rare disease approval under its belt, Alnylam is still revving up the R&D engines for new indications.
STAT+: More Medicare plans cover Humira biosimilars, but do little to encourage patient use
STAT
MAY 8, 2025
Medicare drug plans significantly boosted coverage of biosimilar versions of the Humira rheumatoid arthritis medicine this year, but nearly all of them failed to take steps that would encourage greater use of these alternative treatments, a new government watchdog report finds. The report found that 96% of the Part D plans and 88% of the Medicare Advantage drug plans agreed to cover at least one of the 10 available copycat drugs on their 2025 formularies.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The AHIP premium dollar corrected (again)
PhRMA
MAY 8, 2025
Despite what the insurance industry claims, prescription medicines are not the drivers of insurance premium costs.
Cancer before age 50 is increasing. A new study looks at which types
STAT
MAY 8, 2025
Cancer before age 50 is rare, but increasing, in the United States and researchers want to know why. A new government study provides the most complete picture yet of early-onset cancers , finding that the largest increases are in breast, colorectal, kidney and uterine cancers. Scientists from the National Cancer Institute looked at data that included more than 2 million cancers diagnosed in people 15 to 49 years old between 2010 and 2019.
How to save money on Novolog
The Checkup by Singlecare
MAY 8, 2025
NovoLog (insulin aspart) is a fast-acting, injectable, and FDA-approved insulin thats used to manage blood sugar levels in people with diabetes mellitus. NovoLog is manufactured by Novo Nordisk and is available in 10 mL multiple-dose vials or 3 mL injection pens. A generic version is also available. The price can be an obstacle for some, especially those without insurance.
STAT+: Insitro, an AI biotech founded by Daphne Koller, lays off staff
STAT
MAY 8, 2025
Insitro, the closely watched AI biotech founded by the Stanford professor and entrepreneur Daphne Koller, said Thursday it was laying off 22% of its staff, or around 60 people. It’s part of a series of cuts that have hit well-backed startups over the last couple years, amid a prolonged downturn in biotech fundraising. A few startups have shut down altogether.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Shionogi aims to buy tobacco giant's pharma unit for $1bn
pharmaphorum
MAY 8, 2025
Shionogi has reached a $1.
Opinion: An evidence-based way to make Medicaid less bureaucratic and more efficient
STAT
MAY 8, 2025
As a primary care physician serving Medicaid patients, I recently witnessed a preventable hospitalization that perfectly illustrates America’s health care dysfunction. My homebound patient with heart failure needed a routine lab test to adjust their medication. While commercially insured patients can access electronic lab orders, my patient’s Medicaid plan contracted exclusively with a laboratory requiring physical forms by mail.
FDA announces generative AI pilot and rapid rollout plans
pharmaphorum
MAY 8, 2025
FDA announces generative AI pilot and rapid rollout plans Jonah.
Judge deals blow to compounding pharmacies
STAT
MAY 8, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, we’ve got more news today about Vinay Prasad — let’s get into it.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MAY 8, 2025
Pager Health, a virtual care navigation platform, sees opportunities to use generative AI to help guide health plan members and provide a more personalized experience, like a companion to provide one-on-one support.
B4DT Cognitive Behavioral Therapy Has Sustained Treatment Effects in Patients With Panic Disorders
Pharmacy Times
MAY 8, 2025
These results build off prior studies which demonstrated effectiveness of Bergen 4-day treatment (B4DT) in patients with panic disorders.
Gilead ups its US investment plans by $11 billion
pharmaphorum
MAY 8, 2025
Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US
FDA Grants Fast Track Designation to IBS 2001, An Investigational Trispecific Antibody for Multiple Myeloma
Pharmacy Times
MAY 8, 2025
The agent demonstrated promising tolerability and manageable safety.
RFK Jr launches database project to explore autism causes
pharmaphorum
MAY 8, 2025
A project to use federal databases to identify the "root causes of autism" has been launched by HHS, but there are concerns about its credibility
Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds
Pharmafile
MAY 8, 2025
A global survey by Johnson & Johnson MedTech has revealed that a majority of Europeans are willing to share their health data in exchange for more personalised care signalling growing public trust in the role of technology in healthcare. Conducted between August and September 2024, the survey gathered responses from both the general public […] The post Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds appeared first on Pharmafile.
Obicetrapib Plus Ezetimibe Reduced LDL-C in Patients With or at Risk of Atherosclerotic Cardiovascular Disease
Pharmacy Times
MAY 8, 2025
The fixed-dose combination yielded a 49% greater reduction in low density lipoprotein cholesterol (LDL-C) compared with placebo.
Axtria Ignite 2025: AI-powered pharma leadership and transformation
pharmaphorum
MAY 8, 2025
Join us 4th-5th June 2025 for Axtria Ignite, an event focused on AI-powered pharma leadership and transformation. Don't miss out on this opportunity to learn from industry experts and network with peers.
Coalition of Pharmacy Organizations Urges Congress to Pass ECAPS Legislation
Pharmacy Times
MAY 8, 2025
The Ensuring Community Access to Pharmacist Services (ECAPS) Act would enhance Medicare coverage for pharmacist services and ensure seniors can access essential care in underserved areas.
Fierce Healthcare - Untitled Article
Fierce Healthcare
MAY 8, 2025
A new shareholder lawsuit claims that UnitedHealth Group made misleading statements about its financial outlook following the murder of a prominent company executive.
FDA Approves Avutometinib/Defactinib for Adults With KRAS-Mutated Recurrent LGSOC
Pharmacy Times
MAY 8, 2025
With this approval, avutometinib/defactinib has become the first and only FDA-approved treatment for patients with recurrent low-grade serous ovarian cancer (LGSOC).
Tackling EU supply chain challenges while boosting innovation
European Pharmaceutical Review
MAY 8, 2025
As EU Health Ministries approach the final stages of negotiations on the future of Europes pharmaceutical rules, Medicines for Europe has called for key actions to ensure medicine supply is protected in the region. Alongside other actions, the organisation proposed that health is central to all political decisions and to conclude the EU pharmaceutical reform.
Neoadjuvant Trastuzumab Deruxtecan Improves Pathologic Complete Response in Patients With HER2+ Early Breast Cancer
Pharmacy Times
MAY 8, 2025
Trastuzumab deruxtecan was safe and efficacious prior to treatment with paclitaxel, trastuzumab, and pertuzumab.
Antares Vision Group, Siempharma Strike Up Pharma Labeling Equipment Collaboration
Pharmaceutical Commerce
MAY 8, 2025
The track-and-trace systems provider expands its life sciences portfolio by integrating the high-speed, adaptable ETF-300 precision labeler through a partnership that brings Industry 4.0-ready capabilities, advanced printing tech, and enhanced data security to pharmaceutical packaging.
INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC
Pharmacy Times
MAY 8, 2025
Necrotizing enterocolitis (NEC) is a life-threatening illness that is characterized by the inflammation of the intestinal lining, which can lead to intestinal perforation.
Let's personalize your content